Duke Clin Rsch Institute

Durham, North Carolina 27710

0 studies enrolling now · 5 studies all time

What they study most

Down Syndrome, Multiple Myeloma

Studies at this site

• Study of Bromodomain and Extra-Terminal Protein (BET) Inhibitor RO6870810 as Mono- and Combination Therapy in Advanced Multiple Myeloma — Completed
• A Study of RG1662 in Adults and Adolescents With Down Syndrome (CLEMATIS) — Completed
• Non-drug Study to Evaluate the Suitability of Neurocognitive Tests and Functioning Scales for the Measurement of Cognitive and Functioning Changes in Children With Down Syndrome — Completed
• A Screening Protocol to Assess Adults and Adolescents With Down Syndrome for Eligibility For Upcoming Study of RG1662 (Study BP27832) — Completed
• A Study of RO5186582 in Down Syndrome Among Children 6 to 11 Years of Age — Stopped early